| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 28 |
| 1 | PEMETREXED DISODIUM | 21 |
| 2 | CARBOPLATIN | 16 |
| 3 | PEMETREXED | 15 |
| 4 | CISPLATIN | 14 |
| 5 | ACETAMINOPHEN | 8 |
| 6 | PREDNISOLONE | 8 |
| 7 | PREDNISOLONE ORAL | 8 |
| 8 | PREDNISOLONE ORAL SOLUTION | 8 |
| 9 | ACETAMINOPHEN 500MG | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALCLOMETASONE DIPROPIONATE | 1 | 0.0032 |
| 1 | PLATINUM | 1 | 0.0019 |
| 2 | PRALSETINIB | 3 | 0.0016 |
| 3 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 4 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| 5 | LAZERTINIB | 1 | 0.0012 |
| 6 | SOTORASIB | 4 | 0.0012 |
| 7 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| 8 | PEMETREXED DISODIUM | 21 | 0.0005 |
| 9 | CERITINIB | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 7 | 0.0003 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 30 | 0.0003 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 3 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 5 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 7 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 8 | Platinum-based Drug [EPC] | 28 | 0.0001 |
| 9 | Antimalarial [EPC] | 1 | 0.0001 |